Patient relevant endpoints in oncology: current issues in the context of early benefit assessment in Germany
{{output}}
The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant effect of the new medicines compared to an appropri... ...
